Cargando…

SARS Vaccine Protective in Mice

Detalles Bibliográficos
Autores principales:	Stadler, Konrad, Roberts, Anjeanette, Becker, Stephan, Vogel, Leatrice, Eickmann, Markus, Kolesnikova, Larissa, Klenk, Hans-Dieter, Murphy, Brian, Rappuoli, Rino, Abrignani, Sergio, Subbarao, Kanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2005
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320494/ https://www.ncbi.nlm.nih.gov/pubmed/16110580 http://dx.doi.org/10.3201/eid1108.041003

Ejemplares similares

SARS — beginning to understand a new virus
por: Stadler, Konrad, et al.
Publicado: (2003)

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
por: Bisht, Himani, et al.
Publicado: (2005)

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005)

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
por: Traggiai, Elisabetta, et al.
Publicado: (2004)

Animal Models for Sars
por: Roberts, Anjeanette, et al.
Publicado: (2006)

Is there an ideal animal model for SARS?
por: Subbarao, Kanta, et al.
Publicado: (2006)

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
por: McAuliffe, Josephine, et al.
Publicado: (2004)

Animal models and vaccines for SARS-CoV infection
por: Roberts, Anjeanette, et al.
Publicado: (2008)

Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
por: Vogel, Leatrice N., et al.
Publicado: (2007)

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
por: Yang, Zhi-yong, et al.
Publicado: (2004)

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro
por: Kam, Yiu Wing, et al.
Publicado: (2007)

A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
por: Roberts, Anjeanette, et al.
Publicado: (2007)

Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25–26 August 2005, London, UK
por: Roberts, Anjeanette, et al.
Publicado: (2006)

Characterization of severe acute respiratory syndrome coronavirus membrane protein
por: Voß, Daniel, et al.
Publicado: (2006)

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
por: Houser, Katherine V., et al.
Publicado: (2016)

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
por: Bukreyev, Alexander, et al.
Publicado: (2004)

The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses
por: Paules, Catharine I, et al.
Publicado: (2017)

In Vivo Imaging of Influenza Virus Infection in Immunized Mice
por: Czakó, Rita, et al.
Publicado: (2017)

Eurasian-Origin Gene Segments Contribute to the Transmissibility, Aerosol Release, and Morphology of the 2009 Pandemic H1N1 Influenza Virus
por: Lakdawala, Seema S., et al.
Publicado: (2011)

SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism
por: Frieman, Matthew B., et al.
Publicado: (2010)

131 Replication and assembly of filoviruses
por: Kolesnikova, Larissa, et al.
Publicado: (2014)

Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
por: Houser, Katherine V., et al.
Publicado: (2017)

Can Immunity Induced by the Human Influenza Virus N1 Neuraminidase Provide Some Protection from Avian Influenza H5N1 Viruses?
por: Gillim-Ross, Laura, et al.
Publicado: (2007)

Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial)
por: Tackenberg, Björn, et al.
Publicado: (2018)

The Matrix Protein VP40 from Ebola Virus Octamerizes into Pore-like Structures with Specific RNA Binding Properties
por: Gomis-Rüth, F.Xavier, et al.
Publicado: (2003)

Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein
por: DiCarlo, Andrea, et al.
Publicado: (2007)

The challenge of developing universal vaccines
por: Rappuoli, Rino
Publicado: (2011)

Vaccines, emerging viruses, and how to avoid disaster
por: Rappuoli, Rino
Publicado: (2014)

Timeline: Vaccines
por: Rappuoli, Rino
Publicado: (2020)

From Pasteur to genomics: progress and challenges in infectious diseases
por: Rappuoli, Rino
Publicado: (2004)

Emil Gotschlich: Physician–scientist and vaccine pioneer (1935–2023)
por: Rappuoli, Rino
Publicado: (2023)

Antibody Pressure by a Human Monoclonal Antibody Targeting the 2009 Pandemic H1N1 Virus Hemagglutinin Drives the Emergence of a Virus with Increased Virulence in Mice
por: O’Donnell, Christopher D., et al.
Publicado: (2012)

Interaction with Tsg101 Is Necessary for the Efficient Transport and Release of Nucleocapsids in Marburg Virus-Infected Cells
por: Dolnik, Olga, et al.
Publicado: (2014)

Advances in Influenza Virus Research: A Personal Perspective
por: Subbarao, Kanta
Publicado: (2018)

The Critical Interspecies Transmission Barrier at the Animal–Human Interface
por: Subbarao, Kanta
Publicado: (2019)

SARS-CoV-2: A New Song Recalls an Old Melody
por: Subbarao, Kanta
Publicado: (2020)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine
por: Stein, Markus, et al.
Publicado: (2013)

Novel vaccination strategies
por: Lattanzi, Maria, et al.
Publicado: (2005)

Vaccinology at the beginning of the 21st century
por: Wack, Andreas, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_rm6pbuok96poherrdi43377v83